Patterson UTI COO sells 150,000 shares at $11.47; holdings drop to 421.5K (-26.2%)
James Michael Holcomb, EVP & Chief Operating Officer, sold 150,000 shares (150.0K shares) at $11.47 on 2026-05-28, reducing his post-transaction holdings to 421,523 shares (421.5K shares), a -26.2% reduction in his stake. The sale occurs against a backdrop of deteriorating company fundamentals: Patterson UTI reported a net loss of $-24,627,000.00 ($-24.6M) in its most recent full fiscal year, annual revenue declined -10.2% year-over-year, and the stock is currently -11.8% below its 52-week high. The substantial reduction in the COO's personal position, combined with the company's unprofitable state and negative revenue trajectory, warrants investor attention to near-term operational and strategic developments.